<strong>Efficacy and safety of chidamide-contained protocol for relapsed and refractory peripheral T-cell lymphoma, not otherwise specified</strong>

doi:10.3781/j.issn.1000-7431.2022.2111-0821

Efficacy and safety of chidamide-contained protocol for relapsed and refractory peripheral T-cell lymphoma, not otherwise specified

WEN Qing, HOU Huting, QIAN Siyu, ZHANG Yue, LEI Yaxin, GE Jingjing, KONG Xiaoshuang, WANG Wenhua, ZHANG Mingzhi, ZHANG Xudong, CHEN Qingjiang

PDF(862 KB)

Tumor ›› 2022, Vol. 42 ›› Issue (08) : 562-569. DOI: 10.3781/j.issn.1000-7431.2022.2111-0821

Original Research

Efficacy and safety of chidamide-contained protocol for relapsed and refractory peripheral T-cell lymphoma, not otherwise specified

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 42(08): 562-569 https://doi.org/10.3781/j.issn.1000-7431.2022.2111-0821

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(862 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Accepted	Published
2021-11-01	2022-03-25	2022-08-25
Issue Date
2022-08-25

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

QR code of this article

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS